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Sirs,
We are concerned that the manner in which leukocytes are
prepared for the determination of cystine levels may cause
imprecise results which could adversely affect the treatment of
patients with cystinosis. Leukocyte cystine levels are used to
diagnosecystinosis,monitorCystagontherapy,andformultiple
purposes in research studies. The determination of cystine in
leukocytes is performed only in a small number of laboratories
worldwide, one of which is the Cystine Determination
Laboratory at the University of California San Diego (UCSD).
In the late 1970s, when the first cysteamine treatment
trial was started, we evaluated ways to have blood shipped
to the laboratory for the separation of leukocytes and the
determination of intracellular cystine. It was determined that
the leukocyte cystine level could only reliably be measured
from samples that had been separated immediately after the
blood was drawn. To ensure uniform preparation, our
practice has been to ship reagents to point-of-care clinical
laboratories, with precise instructions for sample preparation
(http://biochemgen.ucsd.edu/cystinosis/), as in the published
method [1]. Separated and lysed leukocyte samples are
acidified, frozen and transported to our laboratory on dry ice
for protein and cystine determinations.
Other laboratories accept heparinized whole blood
shipped on wet ice for the determination of leukocyte
cystine levels. The leukocytes are separated from the
sample upon arrival at the laboratory, typically 24–48 h after
the blood was drawn. This frees the point-of-care laboratory
from the task of preparing the leukocytes, a procedure which
is not complicated but which is time consuming and may be
seen as an inconvenience.
Our laboratory therefore would naturally be interested in
changing the procedure to accept whole blood. However,
based on our experiences in the 1970s, we felt it was
important to evaluate the stability of intracellular cystine in
blood samples during storage and shipping. Until recently,
the demanding cystine binding assay method used for the
cystine assay made such an evaluation impractical, but a
newer method using tandem mass spectrometry [3] has
reduced sample analysis time drastically.
The aim of our small study was to evaluate whether
intracellular cystine levels would be reliable if leukocyte
separation from heparinized whole blood were delayed for up
to 24–48 h, as would be expected withexpress mailshipment.
Three cystinotic patients were enrolled into the study.
Patients on Cystagon therapy were asked to discontinue
therapy 24 h before participating. Blood was drawn from
each subject, with aliquots anticoagulated in Li-heparin or
Na-heparin. Blood was divided into 3-mL samples, and
leukocytes were prepared in triplicate by the ACD-dextran
method immediately after collection (0 h, baseline) or after
being stored for 24±1 or 48±1 h at either room temperature
or 4°C. All reagents for the separation were prepared by the
UCSD Cystine Determination Laboratory. Protein content
was determined using the Lowry method [3], and cystine
content was measured using tandem mass spectrometry [2,
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as the percentage of baseline value. Samples stored for 48
h at room temperature and collected in Li- and Na-heparin,
respectively, did not separate when mixed with ACD-dextran,
and leukocytes could not be isolated from these samples.
Leukocytes could be prepared from all other samples.
No differences were observed between Li- and Na-
heparin, and the results for both anticoagulants were
therefore combined. The levels determined at baseline and
after storage for 24 and 48 h at 4°C and for 24 h at room
temperature are shown in Table 1. Cystine levels in samples
stored for 24 h at room temperature varied between 52 and
117% of baseline values. Even greater variations were
measured when the samples were stored at 4°C for 24
h (37–214%). After 48 h, only samples stored at 4°C could
be separated, and the cystine levels determined were
between 52 and 240% of baseline values.
Although we tested only a small number of samples, we
believe these results clearly show that results will be
imprecise if leukocytes are not prepared immediately after
heparinized blood is drawn. Accordingly, we encourage
nephrologists treating cystinosis patients to take into account
the time involved in storing and shipping samples prior to
separating leukocytes for cystine determination.
We are hoping to expand this study and evaluate
different agents which might stabilize leukocytes and
obviate the need for immediate cell preparation, but we
believe it important to share these results immediately with
all pediatric nephrologists treating cystinosis patients.
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Table 1 Leukocyte cystine levels
a after the storage of whole blood for 24 or 48 h in Li- and Na-heparin (results averaged together) at room
temperature or 4°C before separation of leukocytes
Leukocyte cystine levels
Baseline 24h at 4°C 24h at RT 48h at 4°C 48h at RT
100.0 ± 10.5 120.5 ± 39.6 72.3 ± 18.8 123.26 ± 66.4 –
b
RT, Room temperature
aLeukocyte cystine levels are given as a percentage of the baseline value ± the standard deviation
b Leukocytes could not be separated in samples stored 48 h at RT
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